Published in Proc Natl Acad Sci U S A on December 01, 1978
A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and beta 2-microglobulin genes. Proc Natl Acad Sci U S A (1987) 3.80
Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci U S A (1988) 3.67
Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells. Proc Natl Acad Sci U S A (1982) 3.11
Induction of Ia antigen in rat epidermal cells and gut epithelium by immunological stimuli. J Exp Med (1982) 2.92
Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon. Proc Natl Acad Sci U S A (1985) 2.56
Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells. Proc Natl Acad Sci U S A (1985) 2.35
Molecular cloning and sequence of partial cDNA for interferon-induced (2'-5')oligo(A) synthetase mRNA from human cells. Proc Natl Acad Sci U S A (1983) 1.73
Control of HLA-A,B,C synthesis and expression in interferon-treated cells. EMBO J (1982) 1.69
Interferon increases HLA synthesis in melanoma cells: interferon-resistant and -sensitive cell lines. Proc Natl Acad Sci U S A (1982) 1.29
Human chromosomes 6 and 21 are required for sensitivity to human interferon gamma. Proc Natl Acad Sci U S A (1987) 1.25
Interferon-gamma-like molecule induces Ia antigens on cultured mast cell progenitors. Proc Natl Acad Sci U S A (1982) 1.22
Extracellular matrix-modulated expression of human cell surface glycoproteins A42 and J143. Intrinsic and extrinsic signals determine antigenic phenotype. J Exp Med (1986) 1.11
Cell cycle and the differential expression of HLA-A,B and HLA-DR antigens on human B lymphoid cells. Proc Natl Acad Sci U S A (1980) 1.09
Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta. Infect Immun (1983) 1.06
Regulation of MHC class II invariant chain expression: induction of synthesis in human and murine plasmocytoma cells by arresting replication. EMBO J (1983) 1.04
Sequential induction of MHC antigens on autochthonous cells of ileum affected by Crohn's disease. Am J Pathol (1987) 0.94
Soluble HLA class I antigen secretion by normal lymphocytes: relationship with cell activation and effect of interferon-gamma. Clin Exp Immunol (1990) 0.90
Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection. Gut (1986) 0.88
Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci. Infect Immun (1983) 0.87
Inhibition of growth, transformation, and expression of human papillomavirus type 16 E7 in human keratinocytes by alpha interferons. J Virol (1993) 0.86
Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment. Clin Exp Immunol (1985) 0.84
Molecular analysis of the bare lymphocyte syndrome. J Clin Invest (1985) 0.84
The effects of interferon on the recirculation of lymphocytes in the rat. Immunology (1987) 0.83
Interferon selectively inhibits the expression of mitochondrial genes: a novel pathway for interferon-mediated responses. EMBO J (1990) 0.82
Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast. Am J Pathol (1989) 0.81
Spontaneous cytotoxicity of human peripheral blood mononuclear cells for the lymphoblastoid cell line CCRF-CEM: augmentation by bacterial lipopolysaccharide. Clin Exp Immunol (1981) 0.79
Phorbol esters potentiate the induction of class I HLA expression by interferon alpha. Proc Natl Acad Sci U S A (1989) 0.78
Pleiotropic activities of human interferons are mediated by multiple response pathways. Proc Natl Acad Sci U S A (1984) 0.78
Modulation of polyclonal B cell differentiation by human leucocyte alpha interferon. Clin Exp Immunol (1982) 0.77
Induction of auto-logous human cytotoxic T lymphocytes (CTL) from peripheral blood against tumor cells. Cytotechnology (1997) 0.75
Alpha-interferon induces enhanced expression of HLA-ABC antigens and beta-2-microglobulin in vivo and in vitro in various subsets of human lymphoid cells. Clin Exp Immunol (1987) 0.75
The effect of recombinant interferon-alpha on lymphocyte subpopulations and HLA-DR expression on liver tissue of HBV-positive individuals. Clin Exp Immunol (1990) 0.75
Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature (1974) 13.24
Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: implications for H-antigen diversity. Transplant Rev (1976) 8.10
Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proc Natl Acad Sci U S A (1972) 2.41
Interferon inhibits DNA synthesis induced in mouse lymphocyte suspensions by phytohaemagglutinin or by allogeneic cells. Nat New Biol (1972) 2.12
Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells. Proc Natl Acad Sci U S A (1976) 1.88
Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62
Increased synthesis and expression of H-2 antigens on thymocytes as a result of radiation leukemia virus infection: a possible mechanism for H-2 linked control of virus-induced neoplasia. J Exp Med (1978) 1.53
RELATIONSHIP OF INTERFERON PRODUCTION TO VIRUS GROWTH IN VIVO. Proc Soc Exp Biol Med (1964) 1.49
DIFFERENCES IN INTERFERON CONTENT IN TISSUES OF MICE OF VARIOUS AGES INFECTED WITH COXSACKIE B1 VIRUS. Proc Soc Exp Biol Med (1964) 1.42
Growth inhibition of human lymphoblastoid Daudi cells in vitro by interferon preparations. Arch Virol (1976) 1.10
Inhibitory effect of interferon preparations and inducers on the multiplication of transplanted allogeneic spleen cells and syngeneic bone marrow cells. Nat New Biol (1973) 1.10
Regulation of mitogen-induced lymphocyte DNA synthesis by human interferon of different origins. Cell Immunol (1978) 0.97
Interferon: effects on the immune response and the mechanism of activation of the cellular response. CRC Crit Rev Biochem (1976) 0.96
The actions of interferon are potentiated at elevated temperature. Nature (1978) 0.96
Two small lymphocyte subpopulations in human peripheral blood. I. Purification and surface marker profiles. Int Arch Allergy Appl Immunol (1978) 0.86
Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods (1989) 9.42
Proteins released from Mycobacterium tuberculosis during growth. Infect Immun (1991) 3.69
Conversion of diploidy to haploidy. Nature (2000) 3.28
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer (1997) 2.64
Two antigenically distinct species of human interferon. Proc Natl Acad Sci U S A (1975) 2.59
A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand A (1971) 2.55
Solidarity and equity: new ethical frameworks for genetic databases. Nat Rev Genet (2001) 2.51
The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol (1991) 2.50
T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun (1991) 2.43
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) Circulation (1998) 2.40
Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S) Circulation (1997) 2.34
Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun (1993) 2.27
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation (1996) 2.23
Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination. Lancet (1984) 2.16
Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA (1986) 2.08
Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol (1992) 2.05
Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun (1987) 1.96
Purification of mouse interferon by affinity chromatography on anti-interferon globulin-sepharose. J Immunol (1973) 1.88
Why ruminators are poor problem solvers: clues from the phenomenology of dysphoric rumination. J Pers Soc Psychol (1999) 1.82
Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. Ann Epidemiol (2000) 1.79
5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol (1997) 1.79
Antibody responses against Mycobacterium tuberculosis in 11 strains of inbred mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB.B10 and CBA/J mice. Infect Immun (1988) 1.70
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Intern Med (1996) 1.68
Predicting zygosity in Norwegian twin pairs born 1915-1960. Clin Genet (1983) 1.68
Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies. J Immunol (1975) 1.67
Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet (1985) 1.66
Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun (1990) 1.66
Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62
Molecular heterogeneity in the mild autosomal dominant forms of osteogenesis imperfecta. Am J Hum Genet (1984) 1.62
A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry (2010) 1.61
Ethical aspects of medical genetics. A proposal for guidelines in genetic counseling, prenatal diagnosis and screening. Clin Genet (1985) 1.60
Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg (1992) 1.59
Photochemotherapy of cancer: experimental research. Photochem Photobiol (1992) 1.59
Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet (1985) 1.54
Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease. Clin Genet (1974) 1.54
Acute pain induces an instant increase in natural killer cell cytotoxicity in humans and this response is abolished by local anaesthesia. Br J Anaesth (1999) 1.53
Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). Clin Chem (2000) 1.52
Therapeutic electrical stimulation in cerebral palsy: a randomized, controlled, crossover trial. Dev Med Child Neurol (2001) 1.52
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. Atheroscler Suppl (2004) 1.50
In search of susceptibility genes for type 2 diabetes in West Africa: the design and results of the first phase of the AADM study. Ann Epidemiol (2001) 1.49
Education policy and the heritability of educational attainment. Nature (1985) 1.48
Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat Genet (1993) 1.45
Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels. Cancer Immunol Immunother (1992) 1.45
In vitro stimulation of human lymphocytes by purified cytomegalovirus. Intervirology (1977) 1.45
Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.44
Whole blood folate, homocysteine in serum, and risk of first acute myocardial infarction. Atherosclerosis (1999) 1.43
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering. Am J Cardiol (2000) 1.43
High-density lipoprotein as carrier for amyloid-related protein SAA in rabbit serum. Scand J Immunol (1979) 1.41
Marfan syndrome: exclusion of genetic linkage to the COL1A2 gene. Clin Genet (1986) 1.40
Permanent Committee of the International Congress of Human Genetics. Am J Med Genet (1998) 1.38
Diagnostic accuracy and confusability analyses: an application to the Diagnostic Interview for Genetic Studies. Psychol Med (1996) 1.38
Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res (1997) 1.36
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine (1999) 1.33
ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand (1986) 1.32
Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods (1993) 1.32
Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria. BMJ (1991) 1.30
DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet (1989) 1.26
An inherited X-linked serum system in man; the Xm system. J Exp Med (1966) 1.25
Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine (1987) 1.25
Genetic and environmental contributions to the covariance between occupational status, educational attainment, and IQ: a study of twins. Behav Genet (1989) 1.24
Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand (1987) 1.23
Finding the gene(s) for alcoholism. JAMA (1990) 1.21
Screening for point mutations by semi-automated DNA sequencing using sequenase and magnetic beads. Biotechniques (1993) 1.21
Lipoprotein(a) and atherosclerosis. Ann Intern Med (1991) 1.21
5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol (2000) 1.20
DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clin Genet (1986) 1.20
Oxygen cost of running barefoot vs. running shod. Int J Sports Med (2011) 1.18
Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet (1994) 1.18
A linkage study of phenylketonuria. Clin Genet (1974) 1.18
In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy. Int J Cancer (2001) 1.18
Linkage between familial hypercholesterolemia with xanthomatosis and the C3 polymorphism confirmed. Cytogenet Cell Genet (1978) 1.17
Photosensitizing efficiencies, tumor- and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol (1987) 1.17
Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA). J Exp Med (1983) 1.16
Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun (1992) 1.16
Autosomal dominant myopathy: missense mutation (Glu-706 --> Lys) in the myosin heavy chain IIa gene. Proc Natl Acad Sci U S A (2000) 1.15
Studies on the differentiation of T lymphocytes in sheep. I. Recognition of a sheep T-lymphocyte differentiation antigen by a monoclonal antibody T-80. Immunology (1983) 1.14
Distinct molecular species of human interferons: requirements for stabilzation and reactivation of human leukocyte and fibroblast interferons. J Gen Virol (1975) 1.13
The migration of lymphocytes in the fetal lamb. Eur J Immunol (1979) 1.12
Genetic linkage between the antigenic group (Ag) variation and the apolipoprotein B gene: assignment of the Ag locus. Proc Natl Acad Sci U S A (1986) 1.12
Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Infect Dis (1988) 1.11
Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun (1977) 1.11
The prevalence and phenomenology of self-injurious and aggressive behaviour in genetic syndromes. J Intellect Disabil Res (2010) 1.09
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene (2006) 1.09
Cerebellar ataxia and hypergonadotropic hypogonadism in two kindreds. Chance concurrence, pleiotropism or linkage? Clin Genet (1976) 1.09
Observations of toxic blue-green algae (Cyanobacteria) in some Scandinavian lakes. Acta Vet Scand (1986) 1.08
Blood groups and genetic serum types in diabetes mellitus. Diabetologia (1967) 1.08
Natural killer cells infiltrating colorectal cancer and MHC class I expression. Mol Immunol (2005) 1.08
Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia. Cancer Res (1999) 1.07
The gene for apolipoprotein C-II is closely linked to the gene for apolipo-protein E on chromosome 19. Clin Genet (1984) 1.07
A TaqI RFLP at the EDN1 gene locus. Nucleic Acids Res (1990) 1.07
Plasma N-terminal pro-atrial natriuretic peptide predicts death after premature myocardial infarction, but not as well as radionuclide ejection fraction. A ten-year follow-up study. Scand Cardiovasc J (2001) 1.07
The inheritance of hyperlipoproteinaemia with xanthomatosis. A study of 132 kindreds. Clin Genet (1976) 1.07
Bordetella pertussis and chronic cough in adults. Clin Infect Dis (1999) 1.06
Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers. Int J Cancer (1994) 1.06
Parental determinants of birth weight. Clin Genet (1984) 1.06
Association of parental consanguinity with decreased birth weight and increased rate of early death and congenital malformations. Clin Genet (1985) 1.06
Receiving help at home: the interplay of human and technological assistance. J Gerontol B Psychol Sci Soc Sci (2001) 1.06
Electroimmunoassay of factor IX in hemophilia B. Thromb Res (1975) 1.05
Age-dependent levels of select immunological mediators in sera of healthy children. Clin Diagn Lab Immunol (1998) 1.05